Affordable Access

deepdyve-link
Publisher Website

[French national overview of the inclusion of environmental criteria in the public purchasing of health products (drugs and sterile medical devices)].

Authors
  • Giraud, J-S1
  • Hamidou, F2
  • Hassani, Y2
  • Borel, C2
  • Le Gonidec, P2
  • 1 Observatoire des médicaments, des dispositifs médicaux et de l'innovation thérapeutique d'Île-de-France (OMEDIT), 8, rue Maria Héléna Vieira da Silva, 75014 Paris, France. Electronic address: [email protected] , (France)
  • 2 Observatoire des médicaments, des dispositifs médicaux et de l'innovation thérapeutique d'Île-de-France (OMEDIT), 8, rue Maria Héléna Vieira da Silva, 75014 Paris, France. , (France)
Type
Published Article
Journal
Annales Pharmaceutiques Françaises
Publisher
Elsevier
Publication Date
Mar 01, 2022
Volume
80
Issue
2
Pages
216–226
Identifiers
DOI: 10.1016/j.pharma.2021.06.005
PMID: 34153241
Source
Medline
Keywords
Language
French
License
Unknown

Abstract

Healthcare products (HP) have a significant carbon footprint that must be included by regulation in the facility's purchasing policy. A national overview of the inclusion of environmental criteria (EC) in the public procurement (PP) of HP in hospitals has been carried out. Thirty EC were identified in the literature. Two questionnaires were proposed: (i) for buyers that analyze the level of "importance" and "ease of application" for public tenders (PT), and (ii) for suppliers that declare their commitments and evidence. Six regional buyers and 28 suppliers participated. Buyers recognize the "importance" of sustainable development (SD) but are more reticent about the "applicability" of EC in PT. The environmental rating remains low: on average 4.38 (0.25-10.00) % of the total rating. Only 12 EC are integrated within some PT. Suppliers report a high and diversified commitment to SD: 18 suppliers sent 474 evidence. Buyers and suppliers converge on the optimization of primary packaging and the establishment of a minimum order or delivery group. Since the efficiency of PP is inevitable, EC that combines SD and savings should be prioritized. The integration of additional EC, simple and easily documented, allowing cost containment for both suppliers and buyers, is possible to promote sustainable purchasing. Copyright © 2021 Académie Nationale de Pharmacie. Published by Elsevier Masson SAS. All rights reserved.

Report this publication

Statistics

Seen <100 times